We have a developed a retroviral mediated molecular ablation method to
specifically eliminate HIV Tat-expressing cells. This approach utiliz
es the Tat-inducible HIV-2 promoter and a conditional toxin gene. The
Herpes Simplex Virus thymidine kinase gene product is toxic to mammali
an cells only after treatment with Ganciclovir (GCV) or other nucleosi
de analogues. We demonstrate here that certain promoter modifications
can decrease basal expression while retaining the ability to be transa
ctivated. Furthermore, we show that a HIV-2 promoter thymidine kinase
gene cassette transduced via retroviral vectors into tissue culture ce
lls can specifically promote the ablation of HIV-Tat expressing cells
in the presence GCV. We also show that there is a large differential i
n HIV-thymidine kinase gene transcription and lethal drug dose between
Tat-expressing cells and Tat-negative cells.